r.ilunga
TL2 Moderator · Medellín
Contributes reviews on supplier material. Based in Medellín.
Joined 22 September 2025 · last posted 1d
89 posts, newest first. Showing up to 150.
-
Athletes in weight-category sports: a different risk calculus Replied, post #43 · Clinical › Special populations · 27 Jul 2026 · 0 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
-
What a reversed-phase purity number actually is Replied, post #84 · Analytics › HPLC & UHPLC · 23 Jul 2026 · 13 likes This follows post #81 rather than contradicting it. Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #113 · Analytics › Home & field testing · 22 Jul 2026 · 3 likes On post #109 — agreed on the reasoning, with one qualification. Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay…
-
Coming back to: A structured critique template this community uses Replied, post #65 · Evidence › Study critique · 22 Jul 2026 · 17 likes What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample…
-
Here for the analytics and not much else Replied, post #56 · Lounge › Introductions · 19 Jul 2026 · 16 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #87 · Access › International · 17 Jul 2026 · 18 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.
-
What a reversed-phase purity number actually is Replied, post #61 · Analytics › HPLC & UHPLC · 16 Jul 2026 · 3 likes System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was…
-
Aggregate verification data across the directory, with caveats Replied, post #44 · Sourcing › Independent verification · 13 Jul 2026 · 0 likes Worth separating two things that post #40 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Common supplements people ask about, assessed one at a time Replied, post #19 · Practice › Interactions · 7 Jul 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Revisiting: What pooling buys you and what it destroys Replied, post #70 · Evidence › Meta-analyses · 27 Jun 2026 · 0 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
-
How to disagree with an answer you were given, well Replied, post #14 · Start Here › How to Ask · 24 Jun 2026 · 8 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #60 · Practice › Administration · 24 Jun 2026 · 0 likes Picking up post #57: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #102 · Sourcing › Logistics · 15 Jun 2026 · 6 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #43 · Analytics › Home & field testing · 5 Jun 2026 · 30 likes post #42 is right about the mechanism and I think understates the practical bit. False positives and false negatives: no test has 100% sensitivity and 100% specificity.…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #96 · Compounds › Tirzepatide · 27 May 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #93 · Research Methods › Statistics · 1 May 2026 · 0 likes Coming back to post #91, because the follow-up matters more than the original answer. Relative risk and odds ratios: both compare the rate in one group to the rate in…
-
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #18 · Sourcing › Logistics · 1 May 2026 · 2 likes On post #14 — agreed on the reasoning, with one qualification. Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by…
-
An 18-month record including the parts that went badly Replied, post #6 · Outcomes › Progress reports · 28 Apr 2026 · 2 likes Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and activity changes might contribute. Noting the season is useful…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #11 · Analytics › Method validation · 27 Apr 2026 · 13 likes post #10 answers the question as asked. The question underneath it is different. Stability-indicating method: one that can separate a compound from its degradation…
-
Spike-and-recover accuracy for a peptide assay Replied, post #63 · Analytics › Method validation · 9 Apr 2026 · 2 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
-
[2026 update] What a purity-only report leaves out Replied, post #44 · Sourcing › Independent verification · 5 Mar 2026 · 5 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #31 · Sourcing › Vendor reports · 5 Mar 2026 · 3 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
The lowest dose that does anything: is that a real question? Replied, post #52 · Practice › Dosing & titration · 4 Mar 2026 · 26 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Angle of injection and whether 90 degrees is always right Replied, post #106 · Practice › Administration · 25 Feb 2026 · 0 likes This follows post #103 rather than contradicting it. Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #84 · Practice › Dosing & titration · 19 Feb 2026 · 28 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #116 · Sourcing › Independent verification · 10 Feb 2026 · 0 likes This follows post #113 rather than contradicting it. Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #22 · Evidence › Study critique · 2 Feb 2026 · 0 likes post #21 answers the question as asked. The question underneath it is different. Criticise the method, not the author: a paper with a weak design is not a bad paper by…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #3 · Practice › Side effects · 11 Jan 2026 · 19 likes Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during…
-
What I would record differently if I started again — the long version Replied, post #23 · Outcomes › Progress reports · 11 Jan 2026 · 0 likes Coming back to post #21, because the follow-up matters more than the original answer. Seasonal patterns: some people report weight loss is slower in winter than summer.…
-
A partial dose because the pen emptied mid-injection Replied, post #89 · Practice › Administration · 10 Jan 2026 · 33 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #18 · Practice › Interactions · 10 Jan 2026 · 28 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #42 · Regional › UK & Ireland · 6 Jan 2026 · 19 likes This follows post #39 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #26 · Practice › Interactions · 27 Dec 2025 · 11 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
Reverse causation in a cohort study of weight and outcome Replied, post #3 · Evidence › Study critique · 26 Dec 2025 · 32 likes post #2 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #43 · Sourcing › Independent verification · 14 Dec 2025 · 32 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
-
Research-use-only labelling: what it means and what it does not Replied, post #71 · Sourcing › Regulatory · 11 Dec 2025 · 2 likes Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no human data are being used on theoretical grounds. The…
-
Follow-up: Constipation management, with a dietitian's contribution Replied, post #33 · Practice › Side effects · 24 Nov 2025 · 0 likes This follows post #30 rather than contradicting it. Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At extreme…
-
Pen dose counters: what a click does and does not guarantee Replied, post #8 · Devices › Pens & autoinjectors · 12 Nov 2025 · 7 likes On post #4 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Replied, post #5 · Compounds › Tirzepatide · 9 Nov 2025 · 10 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
Reconciling a supplier certificate with an independent result Replied, post #25 · Sourcing › Vendor reports · 7 Nov 2025 · 19 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #33 · Compounds › Oral incretins · 7 Nov 2025 · 0 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #159 · Practice › Reconstitution · 5 Nov 2025 · 26 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
Sleep tracking data and its considerable limitations Replied, post #65 · Wellbeing › Sleep · 23 Oct 2025 · 1 like Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe is weeks to months, not immediate. Improvement often is gradual rather than…
-
Payment mechanics and the recovery options that do not exist Replied, post #32 · Sourcing › Payments · 20 Oct 2025 · 12 likes I read post #30 twice before replying, because I had assumed the opposite. Recurring billing: if a supplier sets up recurring billing by default, understanding the…
-
Follow-up: Why appetite effects are mostly central Replied, post #70 · Pharmacology › Receptor biology · 18 Oct 2025 · 29 likes Worth separating two things that post #66 runs together. Species differences: rodent studies show the same compounds produce effects in rodents that predict human…
-
Second pass at: The mass-error checker and its intended scope Replied, post #25 · Data & Tools › Calculators · 26 Sep 2025 · 0 likes Units: all calculators explicitly require units to be stated. This prevents the decimal-point errors that come from forgetting units. Always verify units in and out.
-
Column chemistry choices for a 40-residue peptide Replied, post #44 · Analytics › HPLC & UHPLC · 24 Sep 2025 · 6 likes System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was…
-
Hepatic impairment and the absence of data Replied, post #34 · Clinical › Special populations · 14 Sep 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #33 · Lounge › Off topic · 12 Sep 2025 · 0 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion.
-
When a preprint is the best available evidence and we say so Replied, post #137 · Evidence › Preprints · 4 Sep 2025 · 5 likes This follows post #134 rather than contradicting it. Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #89 · Access › Insurance & coverage · 22 Aug 2025 · 15 likes post #88 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #22 · Practice › Administration · 16 Aug 2025 · 14 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #71 · Evidence › Trials · 10 Aug 2025 · 0 likes Coming back to post #69, because the follow-up matters more than the original answer. Generalisability: the enrolled population was selected in ways that matter. Entry…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #57 · Clinical › Special populations · 10 Aug 2025 · 0 likes On post #53 — agreed on the reasoning, with one qualification. Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #3 · Evidence › Journal club · 6 Aug 2025 · 2 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
A ten-fold dose error caught before injection — one year on Replied, post #115 · Devices › Syringes & needles · 4 Aug 2025 · 2 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
-
Thyroid function tests during substantial weight change Replied, post #17 · Clinical › Bloodwork · 30 Jul 2025 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Subcutaneous absorption kinetics and site differences Replied, post #16 · Pharmacology › Pharmacokinetics · 18 Jul 2025 · 3 likes Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the oral dose (14 mg) is so much larger than the…
-
Substitution between formats during a shortage Replied, post #21 · Access › Shortages · 11 Jul 2025 · 0 likes Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are and following their communication is useful.
-
Interim analyses and stopping rules — does this still hold? Replied, post #23 · Evidence › Trials · 1 Jul 2025 · 10 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #38 · Meta › Wiki maintenance · 22 Jun 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #57 · Evidence › Trials · 20 Jun 2025 · 4 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
What a documentation review can and cannot tell you Replied, post #7 · Sourcing › Independent verification · 16 Jun 2025 · 1 like Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #46 · Evidence › Journal club · 27 May 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #43 · Sourcing › Independent verification · 20 May 2025 · 13 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Storing a pen in use versus a pen unopened Replied, post #11 · Devices › Pens & autoinjectors · 2 May 2025 · 1 like Dose counters: pens show the remaining number of doses. When the counter reaches zero, the pen is empty and cannot deliver more. Noting the counter before injection…
-
A ten-fold dose error caught before injection Replied, post #24 · Devices › Syringes & needles · 22 Apr 2025 · 0 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
-
Carryover and the ghost peak from last week's standard Replied, post #36 · Analytics › HPLC & UHPLC · 5 Apr 2025 · 9 likes This follows post #33 rather than contradicting it. Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run…
-
Coverage for the indication versus for the drug — a second dataset Replied, post #40 · Access › Insurance & coverage · 25 Mar 2025 · 0 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #81 · Pharmacology › Receptor biology · 12 Mar 2025 · 33 likes GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in glucose-stimulated insulin secretion. GIP agonism is thought to…
-
Revisiting: Oral versus injected administration claims for BPC-157 Replied, post #4 · marked as the solution · Compounds › Repair & healing peptides · 10 Mar 2025 · 10 likes Worth separating two things that the opening post runs together. Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible in a…
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #22 · Evidence › Journal club · 3 Mar 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #4 · Sourcing › Regulatory · 27 Feb 2025 · 21 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #58 · Analytics › COA interpretation · 25 Jan 2025 · 1 like Worth separating two things that post #54 runs together. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the…
-
Contributing data without breaching anyone's privacy — what changed since Started this topic · Data & Tools › Datasets · 22 Jan 2025 · 1 like On the subject in the title: Contributing data without breaching anyone's privacy — what changed since Working notes rather than a conclusion. A documentation question…
-
When "no data" is the complete and final answer Replied, post #71 · Compounds › Other compounds · 20 Jan 2025 · 17 likes I read post #69 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Fixed versus detachable needles: the trade-offs Replied, post #62 · Devices › Syringes & needles · 21 Dec 2024 · 27 likes Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous injection, 27-30G is typical. Finer needles take…
-
People with a low starting BMI: where the evidence stops Replied, post #19 · Clinical › Special populations · 28 Nov 2024 · 3 likes Hepatic impairment: less is known about dosing in significant liver disease than in kidney disease. Extreme caution applies because the liver metabolises a large…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #135 · Compounds › Repair & healing peptides · 24 Nov 2024 · 16 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #12 · Nutrition & Training › Protein & intake · 19 Nov 2024 · 9 likes post #11 answers the question as asked. The question underneath it is different. Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #89 · Practice › Dosing & titration · 23 Oct 2024 · 10 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Requesting a page: what makes a good request — what changed since Replied, post #43 · Documentation › Wiki requests · 10 Oct 2024 · 9 likes This follows post #40 rather than contradicting it. Scope creep: if you think a page is attempting too much and should be split into multiple pages, that is a…
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #18 · Practice › Side effects · 5 Oct 2024 · 6 likes post #17 is right about the mechanism and I think understates the practical bit. Injection site reaction: local erythema, nodules, or induration at injection sites is…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #19 · Compounds › Tirzepatide · 20 Sep 2024 · 1 like Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #45 · Compounds › Semaglutide · 10 Sep 2024 · 0 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #22 · Devices › Syringes & needles · 17 Aug 2024 · 3 likes This follows post #19 rather than contradicting it. Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub).…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #91 · Compounds › Retatrutide · 22 Jul 2024 · 13 likes The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #102 · Practice › Dosing & titration · 9 Jul 2024 · 2 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
Assessing a warm arrival: the decision process — one year on Replied, post #42 · Sourcing › Logistics · 30 May 2024 · 12 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.